Human Vaccines & Immunotherapeutics
HPV vaccine coverage among adults aged 27-45: Implications for oropharyngeal cancer prevention
Cross-sectional study of 8,745 peoplePopulations
Declared ties to: Pfizer, Merck & Co., Moderna and 1 more
The paper
Duke University
Human Vaccines & Immunotherapeutics, 5 Oct 2026



